Inogen, Inc. (INGN)
6.155
+0.02
(+0.41%)
USD |
NASDAQ |
Mar 19, 16:00
6.155
0.00 (0.00%)
After-Hours: 20:00
Inogen EPS Diluted (Quarterly) : -0.2622 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Boston Scientific Corp. | 0.4493 |
| Globus Medical, Inc. | 1.029 |
| Corcept Therapeutics, Inc. | 0.1994 |
| Cytokinetics, Inc. | -1.495 |
| Apellis Pharmaceuticals, Inc. | -0.4654 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.127M |
| Revenue (Quarterly) | 81.72M |
| Total Expenses (Quarterly) | 88.85M |
| Enterprise Value | 63.54M |
| Gross Profit Margin (Quarterly) | 49.28% |
| Profit Margin (Quarterly) | -8.72% |
| Earnings Yield | -13.93% |
| Normalized Earnings Yield | -13.93 |